Search images on Google      Product Monograph

Active Ingredients:

• insulin glargine, 300 UNIT/ML

DIN: 02493373

Dosage Form(s): SOLUTION

Route(s) of Administration: SUBCUTANEOUS

Description: 3 ML (900 IU) PREFILLED PEN

Schedule: Schedule D

Company: SANOFI-AVENTIS CANADA INC  –  official site

ATC:

• A10 - DRUGS USED IN DIABETES (ATC, WHO, Wiki)
• A10A - INSULINS AND ANALOGUES (ATC, WHO)
• A10AE - Insulins and analogues for injection, long-acting (ATC, WHO)
• A10AE04 - INSULIN GLARGINE (WHO)

Reference brand drug: Lantus

Pharmaceutical standard: MFR

 

External Links for Toujeo Doublestar:

Search on Google

• Toujeo Doublestar side effects
• Toujeo Doublestar dosage
• insulin glargine side effects
• insulin glargine dosage

Sanofi-Aventis Canada Inc

Go to Sanofi-Aventis website to see drug product details. Sometimes you can find toujeo doublestar photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.